PEPTIDES Tirzepatide (Tirzepatide GIP and GLP-1 Receptor Agonist) IN VIALS

What is Tirzepatide (GIP and GLP-1 Receptor Agonist)?

Tirzepatide is a novel peptide-based medication that acts as a dual agonist for GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptors. These receptors play critical roles in regulating blood sugar levels, and Tirzepatide’s dual action enhances the body’s ability to control glucose, especially in individuals with Type 2 diabetes. It also has strong weight-loss effects due to its impact on appetite regulation and metabolism.

Tirzepatide Benefits

Tirzepatide offers a wide range of therapeutic effects, including:

Blood Sugar Regulation: Enhances insulin secretion and reduces glucagon release, leading to improved glucose control, especially in individuals with diabetes.

Weight Loss: It has demonstrated remarkable effects on weight reduction by regulating appetite and metabolism, making it effective for both diabetic and non-diabetic individuals.

Improved Cardiovascular Health: Tirzepatide may help reduce cardiovascular risks by improving cholesterol levels and lowering blood pressure.

Anti-inflammatory Properties: It has been found to reduce inflammation, which may benefit individuals suffering from chronic inflammatory conditions like diabetes.

ALSO KNOWN AS:

GIP and GLP-1 Receptor Agonist
Tirzepatide

Tirzepatide (GIP and GLP-1 Receptor Agonist) DOSAGE:

Tirzepatide (GIP and GLP-1 Receptor Agonist) 10mg/vial

Tirzepatide PEPTIDE INJECTIONS PACKAGE CONTENT:

1 Box of 1 Vial

HOW TO USE Tirzepatide PEPTIDE:

Tirzepatide is injected subcutaneously, generally once per week. The dosage should be adjusted based on blood glucose control and side effects, with weekly monitoring by a healthcare provider to optimize treatment.